Immune-mediated drug-induced liver disease (Q34936720)

5 August 2017

1 reference

title

Immune-mediated drug-induced liver disease (English)

1 reference

5 August 2017

Zhang-Xu Liu

1

1 reference

PubMed ID

12362579

5 August 2017

Neil Kaplowitz

series ordinal

2

1 reference

5 August 2017

1 August 2002

1 reference

5 August 2017

Clinics in liver disease

1 reference

5 August 2017

6

1 reference

5 August 2017

3

1 reference

5 August 2017

755-774

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

5 August 2017

1 reference

7 January 2021

Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Drug-induced liver injury: mechanisms and test systems.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Drug-induced liver disorders: implications for drug development and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Immunotoxicology of the liver: adverse reactions to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Idiosyncratic drug reactions: the reactive metabolite syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Drug-protein conjugation and its immunological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Presence of functional cytochrome P-450 on isolated rat hepatocyte plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Signal recognition particle is required for co-translational insertion of cytochrome P-450 into microsomal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Immune mechanisms in tienilic acid associated hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

The lymphoid liver: considerations on pathways to autoimmune injury

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

The appearance of T cells bearing self-reactive T cell receptor in the livers of mice injected with bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Mouse CD1-specific NK1 T cells: development, specificity, and function

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Strange brew: T cells in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

NKT cells: facts, functions and fallacies.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Immunoallergic drug-induced hepatitis: lessons from halothane

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Ticrynafen-associated hepatic injury: analysis of 340 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Human anti-endoplasmic reticulum autoantibodies produced in aromatic anticonvulsant hypersensitivity reactions recognise rodent CYP3A proteins and a similarly regulated human P450 enzyme(s)

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Non-monooxygenase cytochromes P450 as potential human autoantigens in anticonvulsant hypersensitivity reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Familial occurrence of hypersensitivity to phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Minocycline-induced hepatitis with autoimmune features and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Minocycline as a cause of drug-induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Study of immune reactivity of minocycline-induced chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Acute hepatitis induced by greater celandine (Chelidonium majus).

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Is melatonin associated with the development of autoimmune hepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Allopurinol hepatotoxicity. Report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Pemoline hepatotoxicity in children

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Erythromycin-associated cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Co-amoxiclav jaundice: clinical and histological features and HLA class II association.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Captopril-associated "pseudocholangitis'. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Genetic predisposition to drug-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Molecular basis of polymorphic drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Halothane hepatitis in three pairs of closely related women

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

HLA antigens in patients with unexplained hepatitis following halothane anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900025-9

7 January 2021

10.1016/S1089-3261(02)00025-9

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12362579